Average Co-Inventor Count = 5.75
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (10 from 2,078 patents)
2. Janssen Pharmaceuticals, Inc. (9 from 159 patents)
3. Addex Pharma, S.a. (5 from 37 patents)
4. Cellzome Limited (21 patents)
5. Ortho-mcneil-janssen Pharmaceuticals, Inc. (1 patent)
19 patents:
1. 11319321 - [1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitors
2. 11053248 - [1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitors
3. 10947242 - [1,2,4]triazolo[1,5and#8208;A]pyrimidine compounds as PDE2 inhibitors
4. 10519162 - 6,7-dihydropyrazolo[1,5-α]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors
5. 10071095 - 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders
6. 10005785 - Substituted 6,7-dihydropyrazolo[1,5-a] pyrazines as negative allosteric modulators of mGlUR2 receptors
7. 9840507 - 5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (BACE)
8. 9828350 - 5,6-dihydro-2H-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (BACE)
9. 9737533 - 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
10. 9271967 - 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
11. 9226930 - 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
12. 9174953 - Bicyclic thiazoles as allosteric modulators of mGluR5 receptors
13. 9040707 - Bicyclic thiazoles as allosteric modulators of mGluR5 receptors
14. 9012448 - 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
15. 8993591 - 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors